<DOC>
	<DOCNO>NCT00335582</DOCNO>
	<brief_summary>In Canada 1 patient 200 dy within 30 day operation . More half death direct result heart relate complication . This cause death happen 4 time often people operation . We effective way stop heart attack . Stress cause heart rate blood pressure go cause heart work harder may reason heart attack . One group drug stop heart work hard decrease number heart related complication BETA-BLOCKERS . We wish add another drug , show reduce heart rate blood pressure , reduce number heart attack operation . CLONIDINE show reduce heart attack operation . Since know good idea stop beta-blockers want see give clonidine well beta-blocker safe desired effect decrease number heart attack . We want find good combination two drug decrease number heart attack . Hypothesis : The addition clonidine chronic b-blockade reduce mortality cardiac morbidity among intermediate-to-high risk patient undergo non-cardiac surgery .</brief_summary>
	<brief_title>EPIC ( Evaluating Perioperative Ischemia Reduction Clonidine )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>1 . Age ≥ 45 year 2 . Current use bblocker therapy &gt; =30 day prior surgery 3 . Undergoing noncardiac surgery expect length stay ≥ 48 hour medical reason 4 . Informed consent 5 . Undergoing major vascular surgery ( exclude carotid endarterectomy , dialysis shunt , vein strip ) OR Meet &gt; = 2of follow criterion : 1 . Coronary artery disease 2 . Congestive heart failure 3 . Stroke transient ischemic attack 4 . Diabetes mellitus require oral hypoglycemic insulin therapy 5 . Preoperative renal insufficiency ( creatinine clearance 60 mL/min ) 6 . Peripheral vascular disease , define follow : history ischemic intermittent claudication rest pain , history revascularization procedure leg , peripheral arterial obstruction &gt; = 50 % luminal diameter 7 . Age &gt; =70 year 8 . Intermediaterisk surgical procedure : intraperitoneal , intrathoracic , carotid endarterectomy , major orthopedic ( hip , knee , spine ) surgery , radical prostatectomy , headandneck surgery Exclusion criterion : meet follow 1 . Prior adverse reaction clonidine a2 agonists 2 . Current use Clonidine a2 agonists 3 . Current congestive heart failure 4 . Only bblocker take patient sotalol 5 . Left ventricular ejection fraction &lt; =40 % 6 . Systolic blood pressure &lt; = 90 mmHg 7 . Concomitant lifethreatening disease likely limit life expectancy &lt; =30 day . 8 . Clinically significant aortic stenosis , define aortic valve area &lt; =1.0 cm2 and/or peak transvalvular pressure gradient &gt; = 25 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>alpha 2 agonist</keyword>
	<keyword>cardiac event</keyword>
	<keyword>non cardiac surgery</keyword>
</DOC>